Home/Filings/4/0001181431-05-039076
4//SEC Filing

HEMOSENSE INC 4

Accession 0001181431-05-039076

CIK 0001127393operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 6:31 PM ET

Size

19.2 KB

Accession

0001181431-05-039076

Insider Transaction Report

Form 4
Period: 2005-07-01
Transactions
  • Conversion

    Series B-3 Preferred Stock

    2005-07-01632,9110 total
    Common Stock (158,227 underlying)
  • Conversion

    Common Stock

    2005-07-01+261,079261,079 total
  • Conversion

    Series C-3 Preferred Stock

    2005-07-01411,4090 total
    Common Stock (102,852 underlying)
Transactions
  • Conversion

    Series B-3 Preferred Stock

    2005-07-01632,9110 total
    Common Stock (158,227 underlying)
  • Conversion

    Series C-3 Preferred Stock

    2005-07-01411,4090 total
    Common Stock (102,852 underlying)
  • Conversion

    Common Stock

    2005-07-01+261,079261,079 total
Transactions
  • Conversion

    Common Stock

    2005-07-01+261,079261,079 total
  • Conversion

    Series B-3 Preferred Stock

    2005-07-01632,9110 total
    Common Stock (158,227 underlying)
  • Conversion

    Series C-3 Preferred Stock

    2005-07-01411,4090 total
    Common Stock (102,852 underlying)
Transactions
  • Conversion

    Common Stock

    2005-07-01+261,079261,079 total
  • Conversion

    Series B-3 Preferred Stock

    2005-07-01632,9110 total
    Common Stock (158,227 underlying)
  • Conversion

    Series C-3 Preferred Stock

    2005-07-01411,4090 total
    Common Stock (102,852 underlying)
Footnotes (4)
  • [F1]Not applicable.
  • [F2]Each share of Series B-3 and C-3 Preferred Stock converted into Common Stock on a 1-for-4 basis immediately prior to the closing of the issuer's initial public offering.
  • [F3]Immediately.
  • [F4]The reported securities are owned directly by GC Technology Fund L.P., and indirectly by GCV Management LLC, as general partner of GC Technology Fund L.P., and Marc Geller and Marc Cellier, as general partners of GCV Management LLC. GCV Management LLC, Mr. Geller and Mr. Cellier disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein.

Issuer

HEMOSENSE INC

CIK 0001127393

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001127393

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 6:31 PM ET
Size
19.2 KB